CassandraX— I’ve been noticing in the scientific

New Post Public Reply Private Reply Replies (2) Message Board
sherlock57 Cassandra X #152323
608
CassandraX—

I’ve been noticing in the scientific literature the use of the phrase “CCR5/CCL5 Axis” when talking about the blockade/inhibition of the CCR5 receptor. I think this is a way of emphasizing the complexity of immune signaling and it’s contingent, reactive nature in human disease. Your persistent (and lengthy!) interrogation of ChatGPT about CCR5 expression and CCL5 signaling really made this explicit. I found it both fascinating and frustrating—frustrating because there are huge gaps in our knowledge of the immune system and ChatGPT can’t tell us what we, as a scientific community, don’t know…

Ohm has a handle on this more than most, and his emphasis on “homeostasis” has been very helpful to me in grasping a hint of the contingency and complexity of all this. His comment in a post a few days ago about a CC5 receptor “retreating” into a cell just blew my mind. I didn’t know receptors do that! And of course, if they can retreat that implies they can also emerge from a cell. And then I couldn’t help but trying to visualize what that might look like… But I digress.)

I wonder if the promotion of homeostasis by leronlimab is one reason we have what appear to be cures in mTNBC? If that makes any sense…

Well Cassandra, the emphasis in your post about CCL5 signaling made me think we should probably be paying more attention to that side of the equation. I recall a comment by Bruce Patterson, back in 2020 TED TALK I believe, who famously said “Covid-19 was a RANTES disease…”

What if metastasis turns out to be a RANTES disease? What if atherosclerosis is a RANTES disease? Fibrosis? AD?

While I don’t have access to ChatGPT, when I google CCR5 questions they often provide an “AI Overview” that digs into the topic a bit. Just for kicks I asked if metastasis is a RANTES disease, and ditto for atherosclerosis. Predictably, Google AI said “No, metastasis is not a RANTES disease” but went on to say its a chemokine that plays a role in cancer progression and metastasis. We know that! But I was a little surprised when I got the following about gunk clogging up the arteries:

"Yes, atherosclerosis is often referred to as a RANTES disease, as the chemokine RANTES (Regulated on activation, normal T cell expressed and secreted) plays a significant role in its development and progression. RANTES is involved in recruiting inflammatory cells to the artery walls, contributing to the formation of atherosclerotic plaques." 


Surprisingly, google AI didn’t mention that RANTES “enhances immune cell adhesion to the endothelium,” which contributes to atherosclerosis… and ChatGPT did (in Cassandra’s post). Score one for ChatGPT!

Well, I’ve been thinking about the post for a few days now and wanted to respond before it was forgotten in the rush of what could be great news soon! Fascinating stuff Cassandra.

Sherlock57

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 25

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Xi Jinping's Vision for China's Financial Evolution

Updated Category News Views 174

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Continue Reading
Curaleaf Eyes Aurora Amid Alternative from Organigram

Updated Category News Views 65

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 123

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Updated Category News Views 64

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Continue Reading
Class Action Targets Coastal Financial Over Missteps

Updated Category News Views 32

New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 86

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 22

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
Multiconsult's Q3 2026 Results: A Gradual Rebound

Updated Category News Views 30

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...

Continue Reading

Top 5 Most Recently Viewed Articles

Mobilizing for Equality: Texas AAPI Community Stands United

Updated Category News Views 275

Mobilizing for Equality: Texas AAPI Community Stands United Communities across Texas are coming together in a powerful display of solidarity against discriminatory Senate Bill 17 (SB 17) and House Bill 17 (HB 17). Both pieces of legislation propose to ban or severely restrict real estate ownership for certain foreign nationals, all while cloaked in the guise of protecting...

Continue Reading
Duke Energy Foundation's Commitment to Community Resilience Grows

Updated Category News Views 252

Duke Energy Foundation's Commitment to Community Resilience Duke Energy Foundation, along with Duke Energy, has made a significant impact by investing over $33 million in nonprofit organizations. This funding supports efforts aimed at enhancing community resilience, emergency preparedness, and disaster relief activities. The partnership extends across multiple states,...

Continue Reading
eCential Robotics Announces New Leaders to Boost Growth in US

Updated Category News Views 111

eCential Robotics Welcomes New Leadership to Accelerate Growth in the U.S. eCential Robotics, an innovator in surgical robotics, is thrilled to announce the recent appointments of Lisa Jacobs as President for North America and Matthieu Ville as Vice President of Marketing. These strategic hires are designed to bolster the company's growth and innovation efforts in the...

Continue Reading
Michelin's Latest Share Buyback Update Everyone Should Know

Updated Category News Views 220

Understanding Michelin's Share Buyback Program Michelin, a leader in tire manufacturing and innovation, is continuously taking steps to enhance its shareholder value. Investors often look for tangible actions reflecting a company's commitment to their financial growth. One of the most significant methods companies utilize to support their stock price and return capital to...

Continue Reading
InterDigital Boosts Third Quarter Forecast Following License Deal

Updated Category News Views 198

InterDigital's Promising New License Agreement and Q3 Outlook Smartphone Licensing Agreement Enhances Revenue Predictions Recently, InterDigital, Inc. (Nasdaq: IDCC), a prominent player in the mobile technology field, announced an exciting update that significantly alters its revenue expectations for the third quarter. The company has secured a major licensing agreement...

Continue Reading